Vaccine and prior SARS-CoV-2 infection confer long-lasting protection against omicron BA.5

Close Up Scientist using microscope in laboratory room while making medical testing and research

A new study led by Luís Graça, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM, Lisbon) and full professor at the Medical School of the University of Lisbon, and Manuel Carmo Gomes, associate professor with aggregation at the Faculty of Sciences of the University of Lisbon (Ciências ULisboa), both members of the Direção Geral de Saúde (DGS) Technical Committee for Vaccination against COVID-19 (CTVC), and published today in the scientific journal Lancet Infectious Diseases, shows that the protection conferred by hybrid immunity against the SARS-CoV-2 subvariant omicron BA.5, obtained by the infection of vaccinated people, lasts for at least eight months after the first infection.

WhatsApp adds proxy support to bypass internet shutdowns

Previous article

Where is the next COVID variant, pi? A virologist explains why omicron is continuing to dominate

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations